FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Robins

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Tim J Kruser; Minesh Mehta; H Ian Robins
Pseudoprogression after glioma therapy: a comprehensive review.
Paul W Sperduto; John H Suh; Meihua Wang; Maria Werner-Wasik; Mark K. Buyyounouski; William Demas; Deepak Khuntia; Ritsuko Komaki; Lucien A Nedzi; Gad Perry; H Ian Robins; Michael C Schell; Sunjay A Shah; Luis Souhami; Minesh Mehta
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Arnab Chakravarti; Ali Choucair; Jason Christiansen; Walter J Curran; Adam P Dicker; Marisa Dolled-Filhart; Mark Gustavson; Tim Lautenschlaeger; Paul Mischel; Annette Molinaro; H Ian Robins; Christopher J Schultz; Meihua Wang; David G Brachman; Markus Bredel; Minesh Mehta
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Robins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tim J Kruser; Minesh Mehta; H Ian Robins
Pseudoprogression after glioma therapy: a comprehensive review.
Expert review of neurotherapeutics 2013;13(4):389-403.
2013: Paul W Sperduto; John H Suh; Meihua Wang; Maria Werner-Wasik; Mark K. Buyyounouski; William Demas; Deepak Khuntia; Ritsuko Komaki; Lucien A Nedzi; Gad Perry; H Ian Robins; Michael C Schell; Sunjay A Shah; Luis Souhami; Minesh Mehta
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
International journal of radiation oncology, biology, physics 2013;85(5):1312-8.
2013: Arnab Chakravarti; Ali Choucair; Jason Christiansen; Walter J Curran; Adam P Dicker; Marisa Dolled-Filhart; Mark Gustavson; Tim Lautenschlaeger; Paul Mischel; Annette Molinaro; H Ian Robins; Christopher J Schultz; Meihua Wang; David G Brachman; Markus Bredel; Minesh Mehta
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.
International journal of radiation oncology, biology, physics 2013;85(5):1206-11.
2012: Eudocia Q Lee; Victor A Levin; Frank Lieberman; Minesh Mehta; Michael D Prados; H Ian Robins; John J Wright; W K Alfred Yung; Lauren Abrey; Kenneth Aldape; Susan M Chang; Timothy F Cloughesy; Janet E Dancey; Lisa M DeAngelis; Jan Drappatz; Mark R Gilbert; John Kuhn; Kathleen R Lamborn; Patrick Y Wen
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.
Neuro-oncology 2012;14(12):1511-8.
2012: Eudocia Q Lee; Frank S Lieberman; Renee M McGovern; Michael D Prados; Vinay K Puduvalli; Joel M Reid; H Ian Robins; Matthew M Ames; Susan M Chang; Timothy F Cloughesy; Serena Desideri; Jan Drappatz; Igor Espinoza-Delgado; Mark R Gilbert; John G Kuhn; Kathleen R Lamborn; Andrew B Lassman; Jihong Xu; Xiabu Ye; W K Alfred Yung; Patrick Y Wen
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(21):6032-9.
2012: Katherine S Panageas; Andreana L Rivera; H Ian Robins; Brandon G Rocque; Gloria B Roldán Urgoiti; Marc K Rosenblum; David Schiff; Susan A Weaver; Patrick Y Wen; Lauren E Abrey; Kenneth D Aldape; Lynn S Ashby; J Gregory Cairncross; Marc C Chamberlain; Timothy F Cloughesy; Lisa De Angelis; April F Eichler; Barbara J Fisher; Richard M Green; Fabio M Iwamoto; Suresh C Jhanwar; Francois G. Kamar; Keith L Ligon; David N Louis; Warren P Mason; Nina Paleologos; Andrew B Lassman
Initial treatment patterns over time for anaplastic oligodendroglial tumors.
Neuro-oncology 2012;14(6):761-7.
2012: Samir H Patel; Jared R Robbins; H Ian Robins; Andrew D Vassil; Gregory M M Videtic; Franz J Wippold; Jeffrey D Bradley; Laurie E Gaspar; Isabelle Germano; Paiman Ghafoori; Elizabeth M Gore; Mark A Henderson; Stephen T Lutz; Michael W McDermott; Roy A Patchell
ACR Appropriateness Criteria® follow-up and retreatment of brain metastases.
American journal of clinical oncology 2012;35(3):302-6.
2011: Phioanh Leia Nghiemphu; Michael D Prados; H Ian Robins; Alejandro Torres-Trejo; Patrick Y Wen; Lauren E Abrey; Susan M Chang; Timothy F Cloughesy; Lisa M DeAngelis; Alexis Demopoulos; Jan Drappatz; Howard A Fine; Karen Fink; Santosh Kesari; Kathleen R Lamborn; Andrew B Lassman; Frank S Lieberman; Mark G Malkin; Minesh Mehta
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
International journal of radiation oncology, biology, physics 2011;81(5):1422-7.
2011: Deliang Guo; Cynthia Hong; Tiffany T Huang; Akio Iwanami; C David James; Daisuke Kuga; Dominique D Lisiero; Minesh Mehta; Ingo K Mellinghoff; David Akhavan; Ali Nael Amzajerdi; Ivan Babic; Arnab Chakravarti; Timothy F Cloughesy; Julie Dang; Lisa M Deangelis; Jason Dejesus; Beatrice Gini; David Nathanson; Michael D Prados; Robert M Prins; Felicia Reinitz; H Ian Robins; Horacio Soto; Kazuhiro Tanaka; Peter Tontonoz; Patrick Y Wen; Mary Youssef; Shaojun Zhu; Paul S Mischel
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
Cancer discovery 2011;1(5):442-56.
2011: Jennifer L Clarke; Michele M Ennis; Lauren Abrey; Kenneth Aldape; Susan M Chang; Timothy F Cloughesy; Lisa M Deangelis; Howard A Fine; Mark R Gilbert; John Kuhn; Kathleen R Lamborn; Frank S Lieberman; Minesh Mehta; Michael D Prados; H Ian Robins; Patrick Y Wen; W K Alfred Yung
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Neuro-oncology 2011;13(10):1118-24.
2011: John F de Groot; Lisa De Angelis; Mark Gilbert; B Nebiyou Bekele; Kevin A Camphausen; Alice Chen; Timothy F Cloughesy; Andrew Lassman; Jun Liu; Minesh Mehta; Yuji Piao; Michael Prados; H Ian Robins; Hai Tran; Patrick Y Wen; Hua-Kang Wu; W K A Yung; John V Heymach
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4872-81.
2011: John F de Groot; Lisa De Angelis; Mark R Gilbert; Edward F Jackson; Kathleen R Lamborn; Andrew B Lassman; Frank S Lieberman; Minesh Mehta; Michael D Prados; H Ian Robins; Kenneth Aldape; Susan M Chang; Alice Chen; Timothy F Cloughesy; Jun Yao; W K Alfred Yung; Patrick Y Wen
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2689-95.
2011: Andrew B Lassman; Fabio M Iwamoto; Timothy F Cloughesy; Kenneth D Aldape; Andreana L Rivera; April F Eichler; David N Louis; Nina Paleologos; Barbara J Fisher; Lynn S Ashby; J Gregory Cairncross; Gloria B Roldán; Patrick Y Wen; Keith L Ligon; David Schiff; H Ian Robins; Brandon G Rocque; Marc C Chamberlain; Warren P Mason; Susan A Weaver; Richard M Green; Francois G. Kamar; Lauren E Abrey; Lisa De Angelis; Suresh C Jhanwar; Marc K Rosenblum; Katherine S Panageas
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors.
Neuro-oncology 2011;13(6):649-59.
2011: Jarrod B Adkison; Wolfgang A Tomé; Songwon Seo; Gregory M Richards; H Ian Robins; Karl Rassmussen; James S Welsh; Peter A Mahler; Steven P Howard
Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy.
International journal of radiation oncology, biology, physics 2011;79(3):835-41.
2011: Bo H Chao; Ticiana Leal; Lisa Lepeak; H Ian Robins
Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.
Thrombosis 2011;2011():530183.
2010: Fabio M Iwamoto; Kathleen R Lamborn; H Ian Robins; Minesh Mehta; Susan M Chang; Nicholas A Butowski; Lisa De Angelis; Lauren E Abrey; Wei-Ting Zhang; Michael D Prados; Howard A Fine
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).
Neuro-oncology 2010;12(8):855-61.
2010: John H Suh; Gregory M M Videtic; Amr M Aref; Isabelle Germano; Brian J Goldsmith; Joseph P Imperato; Karen J Marcus; Michael W McDermott; Mark W McDonald; Roy A Patchell; H Ian Robins; C Leland Rogers; Aaron H Wolfson; Franz J Wippold; Laurie E Gaspar
ACR Appropriateness Criteria: single brain metastasis.
Current problems in cancer 2010;34(3):162-74.
2010: Jeffrey J Raizer; Lauren E Abrey; Andrew B Lassman; Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Kenneth A Aldape; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank Lieberman; Timothy F Cloughesy; H Ian Robins; Janet Dancey; Michael D Prados
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.
Neuro-oncology 2010;12(1):95-103.
2010: Jeffrey J Raizer; Lauren E Abrey; Andrew B Lassman; Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Kenneth Aldape; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank Lieberman; Timothy F Cloughesy; H Ian Robins; Janet Dancey; Michael D Prados
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.
Neuro-oncology 2010;12(1):87-94.
2010: Ticiana Leal; H Ian Robins
Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report.
Cancer chemotherapy and pharmacology 2010;65(2):399-401.
2010: Andrew D Norden; Jeffrey J Raizer; Lauren E Abrey; Kathleen R Lamborn; Andrew B Lassman; Susan M Chang; W K Alfred Yung; Mark R Gilbert; Howard A Fine; Minesh Mehta; Lisa De Angelis; Timothy F Cloughesy; H Ian Robins; Kenneth Aldape; Janet Dancey; Michael D Prados; Frank Lieberman; Patrick Y Wen
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Journal of neuro-oncology 2010;96(2):211-7.
2009: Patrick Y Wen; W K Alfred Yung; Kathleen R Lamborn; Andrew D Norden; Timothy F Cloughesy; Lauren E Abrey; Howard A Fine; Susan M Chang; H Ian Robins; Karen Fink; Lisa De Angelis; Minesh Mehta; Emmanuelle di Tomaso; Jan Drappatz; Santosh kesari; Keith L Ligon; Ken Aldape; Rakesh K Jain; Charles D Stiles; Merrill J Egorin; Michael D Prados
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Neuro-oncology 2009;11(6):853-60.
2009: Gregory M M Videtic; Laurie E Gaspar; Amr M Aref; Isabelle M Germano; Brian Goldsmith; Joseph P Imperato; Karen J Marcus; Michael W McDermott; Mark W McDonald; Roy A Patchell; H Ian Robins; C Leland Rogers; John H Suh; Aaron H Wolfson; Franz J Wippold
American College of Radiology appropriateness criteria on multiple brain metastases.
International journal of radiation oncology, biology, physics 2009;75(4):961-5.
2009: H Ian Robins; Andrew B Lassman; Deepak Khuntia
Therapeutic advances in malignant glioma: current status and future prospects.
Neuroimaging clinics of North America 2009;19(4):647-56.
2009: H Ian Robins; Kyle D Holen
More on reports of esophageal cancer with oral bisphosphonate use.
The New England journal of medicine 2009;360(17):1790; author reply 1791-2.
2009: Gregory M Richards; Wolfgang A Tomé; H Ian Robins; James A Stewart; James S Welsh; Peter A Mahler; Steven P Howard
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
Breast cancer research and treatment 2009;114(2):307-13.
2009: Deliang Guo; Robert M Prins; Julie Dang; Daisuke Kuga; Akio Iwanami; Horacio Soto; Kelly Y Lin; Tiffany T Huang; David Akhavan; M Benjamin Hock; Shaojun Zhu; Ava A Kofman; Steve J Bensinger; William H Yong; Harry V Vinters; Steve Horvath; Andrew D Watson; John Kuhn; H Ian Robins; Minesh Mehta; Patrick Y Wen; Lisa De Angelis; Michael D Prados; Ingo K Mellinghoff; Timothy F Cloughesy; Paul S Mischel
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
Science signaling 2009;2(101):ra82.
2008: Brian Choi; H Ian Robins; Joan Schiller; Minesh Mehta
A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer.
Cancer chemotherapy and pharmacology 2008;63(1):175-9.
2008: Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank S Lieberman; Timothy F Cloughesy; H Ian Robins; Lauren E Abrey; Michael D Prados
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
Neuro-oncology 2008;10(4):631-42.
2008: H Ian Robins; Anne O'Neill; Mark Gilbert; Mark Olsen; Ronald Sapiente; Brian Berkey; Minesh Mehta
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial.
Cancer chemotherapy and pharmacology 2008;62(2):227-33.
2008: Jonathan Knisely; Brian Berkey; Arnab Chakravarti; Al W K Yung; Walter Curran; H Ian Robins; Benjamin Movsas; David G Brachman; Randall H Henderson; Minesh Mehta
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
International journal of radiation oncology, biology, physics 2008;71(1):79-86.
2008: Benjamin W Corn; Jennifer Moughan; Jonathan Knisely; Sherry W Fox; Arnab Chakravarti; W K Alfred Yung; Walter Curran; H Ian Robins; David G Brachman; Randal H Henderson; Minesh Mehta; Benjamin Movsas
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
International journal of radiation oncology, biology, physics 2008;71(1):71-8.
2008: Michael D Prados; W K A Yung; Patrick Y Wen; Larry Junck; Timothy F Cloughesy; Karen Fink; Susan Chang; H Ian Robins; Janet Dancey; John Kuhn
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study.
Cancer chemotherapy and pharmacology 2008;61(6):1059-67.
2008: Kathleen R Lamborn; W K Alfred Yung; Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Lisa De Angelis; H Ian Robins; Frank S Lieberman; Howard A Fine; Karen L Fink; Larry Junck; Lauren E Abrey; Mark R Gilbert; Minesh Mehta; John Kuhn; Kenneth Aldape; Janelle Hibberts; Pamela M Peterson; Michael D Prados
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
Neuro-oncology 2008;10(2):162-70.
2008: Brian S Choi; H Ian Robins
Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
Cancer chemotherapy and pharmacology 2008;61(2):345-6.
2007: John Kuhn; Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Harry S Greenberg; David Schiff; Charles Conrad; Karen L Fink; H Ian Robins; Minesh Mehta; Lisa De Angelis; Jeffrey J Raizer; Kenneth Hess; Kathleen R Lamborn; Janet Dancey; Michael D Prados
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7401-6.
2007: Julie E Chang; Deepak Khuntia; H Ian Robins; Minesh Mehta
Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Clinical advances in hematology & oncology : H&O 2007;5(11):894-902, 907-15.
2007: George M Cannon; Wolfgang A Tomé; H Ian Robins; Steven P Howard
Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme.
Journal of neuro-oncology 2007;83(3):307-11.
2007: Brian S Choi; H Ian Robins
Primary disease resection in metastatic breast cancer improves survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):603-4; author reply 604.
2007: Julie E Chang; H Ian Robins; Minesh Mehta
Therapeutic advances in the treatment of brain metastases.
Clinical advances in hematology & oncology : H&O 2007;5(1):54-64.
2007: H Ian Robins; Susan Chang; Nicholas Butowski; Minesh Mehta
Therapeutic advances for glioblastoma multiforme: current status and future prospects.
Current oncology reports 2007;9(1):66-70.
2006: H Ian Robins; Anne M Traynor; Minesh Mehta
Temozolomide as prophylaxis for brain metastasis in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(7):732-3; author reply 733.
2006: Timothy F Cloughesy; Patrick Y Wen; H Ian Robins; Susan M Chang; Morris D Groves; Karen L Fink; Larry Junck; David Schiff; Lauren E Abrey; Mark R Gilbert; Frank S Lieberman; John Kuhn; Lisa De Angelis; Minesh Mehta; Jeffrey J Raizer; W K Alfred Yung; Kenneth Aldape; John Wright; Kathleen R Lamborn; Michael D Prados
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3651-6.
2006: H Ian Robins; Kimberly Brandt; Walter L Longo
Pathophysiology and management of fever revisited.
The journal of supportive oncology 2006;4(6):265-6; author reply 266.
2006: Michael D Prados; Kathleen R Lamborn; W K Alfred Yung; Kurt A Jaeckle; H Ian Robins; Minesh Mehta; Howard A Fine; Patrick Y Wen; Timothy F Cloughesy; Susan Chang; M Kelly Nicholas; David Schiff; Harry S Greenberg; Larry Junck; Karen Fink; Kenneth Hess; John Kuhn
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Neuro-oncology 2006;8(2):189-93.
2006: H Ian Robins; M Won; Wendy F Seiferheld; Christopher J Schultz; Ali K Choucair; David G Brachman; William F Demas; Minesh Mehta
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.
Neuro-oncology 2006;8(1):47-52.
2005: Timothy F Cloughesy; John Kuhn; H Ian Robins; Lauren E Abrey; Patrick Y Wen; Karen Fink; Frank S Lieberman; Minesh Mehta; Susan Chang; Alfred Yung; Lisa De Angelis; David Schiff; Larry Junck; Morris Groves; Steve Paquette; John Wright; Kathleen R Lamborn; Said M Sebti; Michael Prados
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6647-56.
2005: Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Harry S Greenberg; David Schiff; Charles Conrad; Karen Fink; H Ian Robins; Lisa De Angelis; Jeffrey J Raizer; Kenneth Hess; Kenneth Aldape; Kathleen R Lamborn; John Kuhn; Janet Dancey; Michael D Prados
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
Investigational new drugs 2005;23(4):357-61.
2004: Susan M Chang; John Kuhn; Patrick Y Wen; Harry S Greenberg; David Schiff; Charles Conrad; Karen Fink; H Ian Robins; Timothy F Cloughesy; Lisa De Angelis; Jeffrey Razier; Kenneth Hess; Janet Dancey; Michael D Prados
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs.
Investigational new drugs 2004;22(4):427-35.
2004: Craig A Schulz; Minesh Mehta; Behnam Badie; Cornelius J McGinn; H Ian Robins; Lori Hayes; Richard J Chappell; Jennifer Volkman; Kim Binger; Rhoda Arzoomanian; Kris Simon; Dona Alberti; Chris Feierabend; Kendra Tutsch; Keith A Kunugi; George Wilding; Timothy J Kinsella
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.
International journal of radiation oncology, biology, physics 2004;59(4):1107-15.
2004: Susan M Chang; Michael D Prados; W K Alfred Yung; Howard A Fine; Larry Junck; Harry S Greenberg; H Ian Robins; Minesh Mehta; Karen L Fink; Kurt A Jaeckle; John Kuhn; Kenneth Hess; Clifford Schold
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Cancer 2004;100(8):1712-6.
2004: Michael D Prados; W K Alfred Yung; Kurt A Jaeckle; H Ian Robins; Minesh Mehta; Howard A Fine; Patrick Y Wen; Timothy F Cloughesy; Susan M Chang; M Kelly Nicholas; David Schiff; Harry S Greenberg; Larry Junck; Karen L Fink; Kenneth R Hess; John Kuhn
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Neuro-oncology 2004;6(1):44-54.
2004: Michael D Prados; W K Alfred Yung; Howard A Fine; Harry S Greenberg; Larry Junck; Susan M Chang; M Kelly Nicholas; H Ian Robins; Minesh Mehta; Karen L Fink; Kurt A Jaeckle; John Kuhn; Kenneth R Hess; S Clifford Schold
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
Neuro-oncology 2004;6(1):33-7.
2004: S Clifford Schold; Demetrius M Kokkinakis; Susan M Chang; Mitchel S Berger; Kenneth R Hess; David Schiff; H Ian Robins; Minesh Mehta; Karen L Fink; R L Davis; Michael D Prados
O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas.
Neuro-oncology 2004;6(1):28-32.
2003: H Ian Robins; Christopher G Peterson; Minesh Mehta
Combined modality treatment for central nervous system malignancies.
Seminars in oncology 2003;30(4 Suppl 9):11-22.
2003: A Bakhshandeh; I Bruns; A Traynor; H Ian Robins; K Eberhardt; A Demedts; Eckhard Kaukel; Gabriele Koschel; Ulrich Gatzemeier; Th Kohlmann; K Dalhoff; Eva-Maria Ehlers; Y Gruber; R Zumschlinge; Susanna Hegewisch-Becker; Stefan O Peters; G l Wiedemann
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2003;39(3):339-45.
2003: Anneke M Westermann; G l Wiedemann; Elke Jager; D Jager; Dörthe M Katschinski; Alexander Knuth; P Z Vörde Sive Vörding; J D P van Dijk; J Finet; A Neumann; W Longo; A Bakhshandeh; CL Tiggelaar; W Gillis; H Bailey; Stefan O Peters; H Ian Robins
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
Oncology 2003;64(4):312-21.
2002: H Ian Robins; Susan M Chang; Michael D Prados; W K Alfred Yung; Kenneth Hess; David Schiff; Harry S Greenberg; Karen Fink; Kelly Nicolas; John Kuhn; Timothy F Cloughesy; Larry Junck; Minesh Mehta
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
Neuro-oncology 2002;4(2):109-14.
2002: H Ian Robins; Glenn Liu; Lori Hayes; Minesh Mehta
Trastuzumab for breast cancer-related carcinomatous meningitis.
Clinical breast cancer 2002;2(4):316.
2001: Dörthe M Katschinski; E L Jacobson; G l Wiedemann; H Ian Robins
Modulation of VP-16 cytotoxicity by carboplatin and 41.8 degrees C hyperthermia.
Journal of cancer research and clinical oncology 2001;127(7):425-32.
2001: Anneke M Westermann; Elizabeth A Grosen; Dörthe M Katschinski; D Jäger; RC Rietbroek; Julian C Schink; CL Tiggelaar; E Jäger; PJ Zum Vörde sive Vörding; A Neuman; Alexander Knuth; J D P van Dijk; G l Wiedemann; H Ian Robins
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2001;37(9):1111-7.
2001: Susan M Chang; John Kuhn; H Ian Robins; S Clifford Schold; Alexander M Spence; Mitchel S Berger; Minesh Mehta; Ian F Pollack; C Rankin; Michael D Prados
A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report.
Cancer 2001;91(2):417-22.
2001: R D Rao; H Ian Robins; Minesh Mehta
Late recurrence of a primitive neuro-ectodermal tumor.
Oncology 2001;61(3):189-91.
2001: R D Rao; H Ian Robins
Non-Hodgkin's tumor and Pancoast's syndrome.
Oncology reports 2001;8(1):165-6.
2000: Peter Gerke; W Filejski; H Ian Robins; G l Wiedemann; Jürgen Steinhoff
Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia.
Journal of cancer research and clinical oncology 2000;126(3):173-7.
2000: S Clifford Schold; John Kuhn; Susan M Chang; M E Bosik; H Ian Robins; Minesh Mehta; A M Spence; D Fulton; Karen L Fink; Michael D Prados
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study.
Neuro-oncology 2000;2(1):34-9.
1999: H Ian Robins; Elizabeth A Grosen; Dörthe M Katschinski; W Longo; CL Tiggelaar; ME Kutz; J Winawer; F Graziano
Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases.
The Journal of rheumatology 1999;26(12):2513-6.
1999: H Ian Robins; Kendra Tutsch; Dörthe M Katschinski; E Jacobson; Minesh Mehta; M Olsen; J D Cohen; CL Tiggelaar; Rhoda Arzoomanian; Dona Alberti; Chris Feierabend; George Wilding
Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2922-31.
1999: Dörthe M Katschinski; H Ian Robins; M Schad; Stilla Frede; Joachim Fandrey
Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
Cancer research 1999;59(14):3404-10.
1999: Dörthe M Katschinski; GJ Wiedemann; W Longo; FR d'Oleire; David Spriggs; H Ian Robins
Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy.
Cytokine & growth factor reviews 1999;10(2):93-7.
1999: Susan M Chang; John Kuhn; H Ian Robins; S Clifford Schold; Alexander M Spence; Mitchel S Berger; Minesh Mehta; ME Bozik; Ian F Pollack; David Schiff; Mark Gilbert; C Rankin; Michael D Prados
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):984-90.
1999: Dörthe M Katschinski; H Ian Robins
Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity.
International journal of cancer. Journal international du cancer 1999;80(1):104-9.
1999: Kendra Tutsch; Rhoda Arzoomanian; Dona Alberti; Mary Beth Tombes; Chris Feierabend; H Ian Robins; David Spriggs; George Wilding
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812).
Investigational new drugs 1999;17(1):63-72.
1999: H Ian Robins; Dörthe M Katschinski; W Longo; Elizabeth A Grosen; George Wilding; W Gillis; C Kraemer; CL Tiggelaar; D Rushing; James A Stewart; David Spriggs; R Love; Rhoda Arzoomanian; Chris Feierabend; Dona Alberti; K Morgan; Kris Simon; FR d'Oleire
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Cancer chemotherapy and pharmacology 1999;43(5):409-14.
1999: Dörthe M Katschinski; Rainer Benndorf; GJ Wiedemann; Daniel Mulkerin; R Touhidi; H Ian Robins
Heat shock protein antibodies in sarcoma patients undergoing 41.8 degrees C whole body hyperthermia.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(1):67-70.
1998: F M Graziano; Dörthe M Katschinski; H Ian Robins
Hyperthermia and AIDS: a critical review.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1998;14(4):417-9.
1998: Susan M Chang; John Kuhn; Jinee Rizzo; H Ian Robins; S Clifford Schold; Alexander M Spence; Mitchel S Berger; Minesh Mehta; ME Bozik; Ian F Pollack; Mark Gilbert; D Fulton; C Rankin; Mary Malec; Michael D Prados
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2188-94.
1998: L P Brauer; B Prieshof; G l Wiedemann; Christoph Weiss; W Kriz; Uda Schramm; H Ian Robins; Horst Pagel
Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity.
Journal of cancer research and clinical oncology 1998;124(10):549-54.
1997: Dörthe M Katschinski; GJ Wiedemann; M Mentzel; Daniel Mulkerin; R Touhidi; H Ian Robins
Influence of circadian rhythm on 41.8 degrees C whole body hyperthermia induction of haematopoietic growth factors.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(6):571-6.
1997: Dörthe M Katschinski; Wolfgang Jelkmann; GJ Wiedemann; M Mentzel; Daniel Mulkerin; R Touhidi; H Ian Robins
Dynamic changes in serum erythropoietin levels in solid tumour patients undergoing 41.8 degrees C whole body hyperthermia and/or chemotherapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(6):563-9.
1997: H Ian Robins; Dörthe M Katschinski; FR d'Oleire; Daniel Mulkerin; GJ Wiedemann
Lack of evidence for whole body hyperthermia-induced changes in MHC and non-MHC immunological function via cytokine induction.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(5):560-2.
1997: RC Rietbroek; Dörthe M Katschinski; MH Reijers; H Ian Robins; AG Geerdink; Kendra Tutsch; FR d'Oleire; Jaap Haveman
Lack of thermal enhancement for taxanes in vitro.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(5):525-33.
1997: G l Wiedemann; H Ian Robins; Dörthe M Katschinski; M Mentzel; FR d'Oleire; ME Kutz; Thomas Wagner
Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status.
Anticancer research 1997;17(4B):2899-902.
1997: Thomas Feyerabend; RA Steeves; G l Wiedemann; Eckart Richter; H Ian Robins
Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies.
Anticancer research 1997;17(4B):2895-7.
1997: H Ian Robins; FR d'Oleire; Elizabeth A Grosen; David Spriggs
Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.
Anticancer research 1997;17(4B):2891-4.
1997: Dörthe M Katschinski; G l Wiedemann; M Mentzel; Daniel Mulkerin; R Touhidi; H Ian Robins
Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
Cancer letters 1997;115(2):195-9.
1997: FR d'Oleire; Dörthe M Katschinski; H Ian Robins
Murine modelling for cytokine induction.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(3):337-9.
1997: GJ Wiedemann; Dörthe M Katschinski; M Mentzel; Daniel Mulkerin; H Ian Robins
Intracorporeal whole body hyperthermia: toxicity assessment.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(2):249-50.
1997: ME Kutz; Daniel Mulkerin; G l Wiedemann; Dörthe M Katschinski; H Ian Robins
In vitro studies of the hyperthermic enhancement of activated ifosfamide (4-hydroperoxy-ifosfamide) and glucose isophosphoramide mustard.
Cancer chemotherapy and pharmacology 1997;40(2):167-71.
1997: H Ian Robins; D Rushing; ME Kutz; Kendra Tutsch; CL Tiggelaar; D Paul; David Spriggs; C Kraemer; W Gillis; Chris Feierabend; Rhoda Arzoomanian; W Longo; Dona Alberti; FR d'Oleire; R P Qu; George Wilding; James A Stewart
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):158-64.
1996: G J Wiedemann; H Ian Robins; Dörthe M Katschinski; M Mentzel; R van Heek; R Touhidi; Peter Bucsky; W Gillis; Thomas Feyerabend; FR d'Oleire; C Freund; Sawas Eleftheriadis; Christoph Weiss; T Wagner
[Clinical studies on combination of ifosfamide, carboplatin and etoposide (ICE) with whole body hyperthermia].
Medizinische Klinik (Munich, Germany : 1983) 1996;91(5):279-83.
1996: G J Wiedemann; H Ian Robins; S Gutsche; M Mentzel; M Deeken; Dörthe M Katschinski; Sawas Eleftheriadis; R Crahé; Christoph Weiss; B Storer; T Wagner
Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):888-92.
1996: Thomas Feyerabend; R Steeves; G J Wiedemann; Christoph Weiss; T Wagner; Eckart Richter; H Ian Robins
Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies.
Oncology 1996;53(3):214-20.
1996: J P Woods; C L Schmitt-Tiggelaar; FR d'Oleire; R C Rosenthal; H Ian Robins
Hematological effects of radiant heat-induced whole body hyperthermia on dogs.
Canadian journal of veterinary research = Revue canadienne de recherche vétérinaire 1996;60(1):75-8.
1995: H Ian Robins; ME Kutz; G J Wiedemann; Dörthe M Katschinski; D Paul; Elizabeth A Grosen; CL Tiggelaar; David Spriggs; W Gillis; FR d'Oleire
Cytokine induction by 41.8 degrees C whole body hyperthermia.
Cancer letters 1995;97(2):195-201.
1995: H Ian Robins; FR d'Oleire; ME Kutz; A Bird; C L Schmitt-Tiggelaar; J D Cohen; David Spriggs
Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermia.
Cancer letters 1995;89(1):55-62.
1995: J P Woods; C L Schmitt; R C Rosenthal; FR d'Oleire; H Ian Robins
Canine bone marrow as a potential thermal sanctuary during the plateau phase of 41.8 degrees C whole body hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1995;11(1):49-57.
1994: FR d'Oleire; ME Kutz; A Bird; H Ian Robins
Step down heating and melphalan: cytotoxic interactions and clinical implications.
Melanoma research 1994;4(5):303-5.
1994: H Ian Robins; J P Woods; C L Schmitt; J D Cohen
A new technological approach to radiant heat whole body hyperthermia.
Cancer letters 1994;79(2):137-45.
1993: H Ian Robins; J D Cohen; C L Schmitt; Kendra Tutsch; Chris Feierabend; Rhoda Arzoomanian; Dona Alberti; FR d'Oleire; W Longo; C Heiss
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1787-94.
1992: Kelli F Koltyn; H Ian Robins; C L Schmitt; J D Cohen; W P Morgan
Changes in mood state following whole-body hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1992;8(3):305-7.
1991: E Tapazoglou; J D Cohen; C L Schmitt; A Khatana; S A Sapareto; H Ian Robins
Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow.
British journal of cancer 1991;64(3):528-30.
1991: H Ian Robins; G G Jonsson; Elaine L Jacobson; C L Schmitt; J D Cohen; M K Jacobson
Effect of hyperthermia in vitro and in vivo on adenine and pyridine nucleotide pools in human peripheral lymphocytes.
Cancer 1991;67(8):2096-102.
1991: H Ian Robins
Combined modality clinical trials for favorable B-cell neoplasms: lonidamine plus whole body hyperthermia and/or total body irradiation.
Seminars in oncology 1991;18(2 Suppl 4):23-7.
1991: H Ian Robins; A Hugander; M Besozzi; C L Schmitt; P A Martin; L V Zager; J Grossman
Beta-blockade during whole-body hyperthermia: a toxicity study in the dog.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1991;7(2):263-70.
1990: J D Cohen; H Ian Robins
Thermal enhancement of tetraplatin and carboplatin in human leukaemic cells.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1990;6(6):1013-7.
1990: H Ian Robins; D S Neuberg; Al B Benson; K J Pandya; D C Tormey
Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.
Investigational new drugs 1990;8(4):397-9.
1990: J D Cohen; H Ian Robins
Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines.
Investigational new drugs 1990;8(2):137-42.
1990: H Ian Robins; W L Longo; R A Steeves; J D Cohen; C L Schmitt; A J Neville; S O'Keefe; R Lagoni; C Riggs
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
International journal of radiation oncology, biology, physics 1990;18(4):909-20.
1989: J D Cohen; H Ian Robins; C L Schmitt; Martin A Tanner
Interactions of thymidine, hyperthermia, and cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in human T-cell leukemia.
Cancer research 1989;49(21):5805-9.
1989: H Ian Robins; K M Sielaff; B Storer; M J Hawkins; Ernest C Borden
Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer.
Cancer research 1989;49(6):1609-15.
1989: J D Cohen; H Ian Robins; C L Schmitt
Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide.
Cancer letters 1989;44(3):205-10.
1988: H Ian Robins; W L Longo; R K Lagoni; A J Neville; A Hugander; C L Schmitt; C Riggs
Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
Cancer research 1988;48(22):6587-92.
1988: H Ian Robins; W L Longo; R A Steeves; R K Lagoni; A Hugander; A J Neville; S O'Keefe; W Giese; C L Schmitt
A pilot study of whole body hyperthermia and local irradiation for advanced non-small cell lung cancer confined to the thorax.
International journal of radiation oncology, biology, physics 1988;15(2):427-31.
1988: J D Cohen; H Ian Robins; R Timothy Mulcahy; Jerry J Gipp; N Bouck
Interactions between hyperthermia and irradiation in two human lymphoblastic leukemia cell lines in vitro.
Cancer research 1988;48(13):3576-80.
1988: H Ian Robins; R A Steeves; C L Schmitt; C Peterson; P A Martin
A hyperthermia study of differential sensitivity and thermotolerance in AKR murine leukemia and normal bone marrow cells.
International journal of radiation oncology, biology, physics 1988;14(5):979-82.
1987: R A Steeves; H Ian Robins; K Miller; P Martin; L Shecterle; W Dennis
Interaction of whole-body hyperthermia and irradiation in the treatment of AKR mouse leukemia.
International journal of radiation biology and related studies in physics, chemistry, and medicine 1987;52(6):935-47.
1987: H Ian Robins; Ned H Kalin; Steven E Shelton; P A Martin; L M Shecterle; C M Barksdale; A J Neville; J Marshall
Rise in plasma beta-endorphin, ACTH, and cortisol in cancer patients undergoing whole body hyperthermia.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1987;19(9):441-3.
1987: H Ian Robins; Ned H Kalin; Steven E Shelton; L M Shecterle; C M Barksdale; P A Martin; J Marshall
Neuroendocrine changes in patients undergoing whole body hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1987;3(2):99-105.
1985: H Ian Robins; W H Dennis; A J Neville; L M Shecterle; P A Martin; J Grossman; T E Davis; S R Neville; W K Gillis; B F Rusy
A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat device.
Cancer research 1985;45(8):3937-44.
1985: H Ian Robins; T E Davis; R A Steeves; A Hugander; P P Carbone
New therapeutic approaches to low-grade B cell neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(7):1042.
1984: H Ian Robins; W H Dennis; P A Martin; Paul M Sondel; M B Yatvin; R A Steeves
Potentiation of differential hyperthermic sensitivity of AKR leukemia and normal bone marrow cells by lidocaine or thiopental.
Cancer 1984;54(12):2831-5.
1984: H Ian Robins; R A Steeves; L M Shecterle; P A Martin; K A Miller; Bhudatt Paliwal; A J Neville; W H Dennis
Whole body hyperthermia (41-42 degrees C): a simple technique for unanesthetized mice.
Medical physics 1984;11(6):833-9.
1984: A J Neville; H Ian Robins; P Martin; K W Gilchrist; W H Dennis; R A Steeves
Effect of whole body hyperthermia and BCNU on the development of radiation myelitis in the rat.
International journal of radiation biology and related studies in physics, chemistry, and medicine 1984;46(4):417-20.
1984: H Ian Robins; W H Dennis; R A Steeves; Paul M Sondel
A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(9):1050-6.
1983: H Ian Robins; L M Shecterle; J P Aubuchon; B R Paliwal; T E Davis; W H Dennis
Whole body hyperthermia with a microwave regional boost: unexpected toxicity in the pig.
International journal of radiation biology and related studies in physics, chemistry, and medicine 1983;44(5):469-73.
1983: H Ian Robins; R A Steeves; A W Clark; P A Martin; K Miller; W H Dennis
Differential sensitivity of AKR murine leukemia and normal bone marrow cells to hyperthermia.
Cancer research 1983;43(10):4951-5.
1983: H Ian Robins; W H Dennis; J S Slattery; T A Lange; M B Yatvin
Systemic lidocaine enhancement of hyperthermia-induced tumor regression in transplantable murine tumor models.
Cancer research 1983;43(7):3187-91.
1983: H Ian Robins; J Grossman; T E Davis; J P AuBuchon; W Dennis
Preclinical trial of a radiant heat device for whole-body hyperthermia using a porcine model.
Cancer research 1983;43(5):2018-22.